The Effect of Prestudy Insulin Therapy on Safety and Efficacy of Human Regular U-500 Insulin by Pump or Injection: A Posthoc Analysis

Authors: Hood, Robert C., Chen, Yun, Sindelar, Dana K., Ly, Trang, Juneja, Rattan, Pollom, R. Daniel, Ilag, Liza, Wysham, Carol

Source: In Endocrine Practice August 2021 27(8):783-789

Dual Exosite-binding Inhibitors of Insulin-degrading Enzyme Challenge Its Role as the Primary Mediator of Insulin Clearance in Vivo

Authors: Durham, Timothy B., Toth, James L., Klimkowski, Valentine J., Cao, Julia X.C., Siesky, Angela M., Alexander-Chacko, Jesline, Wu, Ginger Y., Dixon, Jeffrey T., McGee, James E., Wang, Yong, Guo, Sherry Y., Cavitt, Rachel Nicole, Schindler, John, Thibodeaux, Stefan J., Calvert, Nathan A., Coghlan, Michael J., Sindelar, Dana K., Christe, Michael, Kiselyov, Vladislav V., Michael, M. Dodson, Sloop, Kyle W.

Source: In Journal of Biological Chemistry 14 August 2015 290(33):20044-20059

LLY-2707, A Novel Nonsteroidal Glucocorticoid Antagonist That Reduces Atypical Antipsychotic–Associated Weight Gain in Rats

Authors: Sindelar, Dana K., Carson, Mathew W., Morin, Michelle, Shaw, Janice, Barr, Robert J., Need, Anne, Alexander-Chacko, Jesline, Coghlan, Michael, Gehlert, Donald R. ^*

Source: In The Journal of Pharmacology and Experimental Therapeutics January 2014 348(1):192-201

5-HT1A receptor antagonists reduce food intake and body weight by reducing total meals with no conditioned taste aversion

Authors: Dill, M. Joelle, Shaw, Janice, Cramer, Jeff, Sindelar, Dana K.

Source: In Pharmacology, Biochemistry and Behavior 1 November 2013 112:1-8

Activation of mesolimbic dopamine neurons during novel and daily limited access to palatable food is blocked by the opioid antagonist LY255582.

Authors: Sahr, Allison E., Sindelar, Dana K., Alexander-Chacko, Jesline T.

Source: American Journal of Physiology; August 2008 pt2, Vol. 295 Issue 2, pR463-R471, 9p

Attenuated feeding responses to circadian and palatability cues in mice lacking neuropeptide Y

Authors: Sindelar, Dana K., Palmiter, Richard D., Woods, Stephen C., Schwartz, Michael W.

Source: In Peptides 2005 26(12):2597-2602

The direct effects of catecholamines on hepatic glucose production occur via α2-and β2-receptors in the dog.

Authors: Chu, Chang An, Sindelar, Dana K., Igawa, Kayano

Source: American Journal of Physiology; August 2000 pt1, Vol. 279 Issue 2, pE463-E473, 11p

Central H3R activation by thioperamide does not affect energy balance

Authors: Sindelar, Dana K ^*, Shepperd, Mary L, Pickard, Richard T, Alexander-Chacko, Jesline, Dill, M.Joelle, Cramer, Jeffrey W, Smith, Dennis P, Gadski, Robert

Source: In Pharmacology, Biochemistry and Behavior 2004 78(2):275-283

Effect of a selective rise in hepatic artery insulin on hepatic glucose production in the conscious dog.

Authors: Sindelar, Dana K., Igawa, Kayano, Chu, Chang A.

Source: American Journal of Physiology; April 1999 pt1, Vol. 276 Issue 4, pE806-E813, 8p

Effect of a selective rise in sinusoidal norepinephrine on HGP is due to an increase in glycogenolysis.

Authors: Chu, Chang An, Sindelar, Dana K., Neal, Doss W.

Source: American Journal of Physiology; January 1998 pt 1, Vol. 274 Issue 1, pE162-E171, 10p

Interaction of equal increments in arterial and portal vein insulin on hepatic glucose production in the dog.

Authors: Sindelar, Dana K., Chu, Chang A., Neal, Doss W.

Source: American Journal of Physiology; November 1997 pt 1, Vol. 273, pE972-E980, 9p

Direct effects of catecholamines on hepatic glucose production in conscious dog are due to glycogenolysis.

Authors: Chu, Chang An, Sindelar, Dana K., Neal, Doss W.

Source: American Journal of Physiology; July 1996 pt1, Vol. 271, pE127-E137, 11p

Hepatic and gut clearance of catecholamines in the conscious dog

Authors: Chu, Chang An, Sindelar, Dana K., Neal, Doss W., Cherrington, Alan D.

Source: In Metabolism February 1999 48(2):259-263

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Synthesis and SAR of novel histamine H3 receptor antagonists

Authors: Jesudason, Cynthia D., Beavers, Lisa S., Cramer, Jeffrey W., Dill, Joelle, Finley, Don R., Lindsley, Craig W., Stevens, F. Craig, Gadski, Robert A., Oldham, Samuel W., Pickard, R. Todd, Siedem, Christopher S., Sindelar, Dana K., Singh, Ajay, Watson, Brian M., Hipskind, Philip A.

Source: In Bioorganic & Medicinal Chemistry Letters 1 July 2006 16(13):3415-3418

Assessment of Stress-Independent Binge-Like Eating Behavior in Mice.

Authors: Czyzyk, Traci A., Alexander-Chacko, Jesline, Dill, Joelle, Sindelar, Dana K., Statnick, Michael A.

Source: Animal Models of Eating Disorders; 2013, p69-81, 13p

This result is not displayed to guests.
Login for full access.

Interaction of free fatty acids and epinephrine in regulation hepatic glucose production in conscious dogs.

Authors: Chang An Chu, Galassetti, Pietro, Igawa, Kayano, Sindelar, Dana K., Neal, Doss W., Burish, Mark, Cherrington, Alan D.

Source: American Journal of Physiology: Endocrinology & Metabolism; Feb2003, Vol. 47 Issue 2, pE291, 11p, 1 Diagram, 4 Charts, 7 Graphs

Subject Terms: LIPOLYSIS, GLYCOGEN storage disease, CATECHOLAMINES

Attenuation of diabetic hyperphagia in neuropeptide Y--deficient mice.

Authors: Sindelar, Dana K.¹, Mystkowski, Paul¹, Marsh, Donald J.², Palmiter, Richard D.², Schwartz, Michael W.¹ mschwartz@u.washington.edu

Source: Diabetes. Mar2002, Vol. 51 Issue 3, p778-783. 6p. 1 Chart, 4 Graphs.

Subject Terms: *NEUROPEPTIDE Y, *INGESTION